NOTICE IS GIVEN that the Annual General Meeting of the ordinary shareholders of Hexima Limited ABN 64 079 319 314 (“Company“) will be held at KPMG, Level 36, Tower 2, Collins Square, 727 Collins Street, Melbourne, Victoria on Tuesday 21 November 2017 at 11am.
- Hexima doses first patient in phase 1/2a trial of HXP124 as a novel topical treatment for fungal nail infections
- Recruiting patients for fungal nail study
- VIDEO: CSO Marilyn Anderson interviewed by the AAS.
- Hexima AGM 2017 – Presentations and Results
- Hexima receives approval to conduct a phase 1/2a study for fungal nail infections